Deuterated lumateperone

氘代卢美哌隆

Report date: 2026/01/16 15:31:43
NME

Base Information

Drug NameDeuterated lumateperone
Drug Alias NameDeulumateperoneITI-1284ITI-1284 ODT-SL
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptor
Therapy Area/IndicationsAgitationPsychotic DisordersAnxiety Disorders +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[11] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Sa
China Registration ClassN/A

Develop Information

Active CompaniesIntra-Cellular Therapies Inc
Inactive CompaniesN/A
Active IndicationsAgitationPsychotic DisordersAnxiety Disorders +[4] 
Inactive IndicationsDepressionDementia

Other Information

ATC CodeN/A
Related LinksN/A